Gonadal and sexual function in male patients with hairy cell leukemia: lack of adverse effects of recombinant alpha 2-interferon treatment.

Gonadal and sexual function was evaluated in 81 male patients with hairy cell leukemia (HCL). Forty-eight patients were receiving recombinant alpha 2b-interferon (INF) therapy, and 33 patients were receiving no systemic therapy at the time of evaluation. Among 28 patients with stable HCL who were receiving no systemic therapy, elevated serum follicle… CONTINUE READING